Supplementary Tables – The clinical position of ramucirumab-containing regimens for advanced gastric cancer: a review of clinical trial data
dataset
posted on 2022-06-15, 09:06 authored by Taylor & FrancisTaylor & Francis, Satoru Iwasa, Hideaki Bando, Yongzhe Piao, Kenichi Yoshizawa, Kensei Yamaguchi
Supplementary Table 1. Overview of targeted therapeutics approved for advanced gastric cancer
Supplementary Table 2: Published real-world studies on ramucirumab-containing regimens in AGC
Supplementary Table 3. Published clinical studies on ramucirumab-containing regimens in AGC in the first-line setting
Supplementary Table 4. Published clinical studies on ramucirumab-containing regimens in AGC in the third-line and perioperative settings
Supplementary Table 5. New and ongoing studies on ramucirumab in advanced gastric cancer (NCT and jRCT databases)
Funding
Eli Lilly Japan K.K.
History
Usage metrics
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC